このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic

The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.

調査の概要

状態

わからない

条件

詳細な説明

The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.

Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.

Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .

Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.

研究の種類

介入

入学 (予想される)

80

段階

  • フェーズ 4

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Zhejiang
      • Hangzhou、Zhejiang、中国、310009
        • 募集
        • The Second Affiliated Hospital Zhejiang University School of Medicine
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~70年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
  • Age ≧ 18 years old, ≦70 years old
  • Temperature, white blood cells, and hemoglobin were normal before surgery
  • Patient informed consent

Exclusion Criteria:

  • Patients with a history of surgery within six months
  • Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
  • American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
  • Allergic to lidocaine
  • Bradycardia (heart rate < 60 beats/min) or atrioventricular block
  • Mental disorder
  • Patients requiring a right double lumen bronchial catheter

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
プラセボコンパレーター:Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
IV bolus of saline, followed by continuous infusion of saline

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Postoperative pain score
時間枠:Immediately postoperation
Using Visual Analogue Scales
Immediately postoperation
Postoperative pain score
時間枠:1 hour postoperation
Using Visual Analogue Scales
1 hour postoperation
Postoperative pain score
時間枠:4 hours postoperation
Using Visual Analogue Scales
4 hours postoperation
Postoperative pain score
時間枠:8 hours postoperation
Using Visual Analogue Scales
8 hours postoperation
Postoperative pain score
時間枠:24 hours postoperation
Using Visual Analogue Scales
24 hours postoperation
Postoperative pain score
時間枠:48 hours postoperation
Using Visual Analogue Scales
48 hours postoperation

二次結果の測定

結果測定
メジャーの説明
時間枠
Opioid requirement
時間枠:Immediately postoperation
The dosage of opioids was recorded
Immediately postoperation
Opioid requirement
時間枠:1 hour postoperation
The dosage of opioids was recorded
1 hour postoperation
Opioid requirement
時間枠:4 hours postoperation
The dosage of opioids was recorded
4 hours postoperation
Opioid requirement
時間枠:8 hours postoperation
The dosage of opioids was recorded
8 hours postoperation
Opioid requirement
時間枠:24 hours postoperation
The dosage of opioids was recorded
24 hours postoperation
Opioid requirement
時間枠:48 hours postoperation
The dosage of opioids was recorded
48 hours postoperation
Pressing times of PCIA postoperation
時間枠:48 hours postoperation
The pressing times of PCIA within 48 hours postoperation was recorded
48 hours postoperation
Occurrence of nausea and/or vomiting
時間枠:48 hours postoperation
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
48 hours postoperation
Blood level of adrenaline
時間枠:before induction
Perioperative blood level of adrenaline was recorded
before induction
Blood level of adrenaline
時間枠:after incision
Perioperative blood level of adrenaline was recorded
after incision
Blood level of adrenaline
時間枠:immediately after extubation
Perioperative blood level of adrenaline was recorded
immediately after extubation
Blood level of norepinephrine
時間枠:before induction
Perioperative blood level of norepinephrine was recorded
before induction
Blood level of norepinephrine
時間枠:after incision
Perioperative blood level of norepinephrine was recorded
after incision
Blood level of norepinephrine
時間枠:immediately after extubation
Perioperative blood level of norepinephrine was recorded
immediately after extubation
Blood level of adrenocortical
時間枠:before induction
Perioperative blood level of adrenocortical was recorded
before induction
Blood level of adrenocortical
時間枠:after incision
Perioperative blood level of adrenocortical was recorded
after incision
Blood level of adrenocortical
時間枠:immediately after extubation
Perioperative blood level of adrenocortical was recorded
immediately after extubation
Blood level of TNF-alpha
時間枠:before induction
Perioperative blood level of TNF-alpha was recorded
before induction
Blood level of TNF-alpha
時間枠:after incision
Perioperative blood level of TNF-alpha was recorded
after incision
Blood level of TNF-alpha
時間枠:immediately after extubation
Perioperative blood level of TNF-alpha was recorded
immediately after extubation
Blood level of IL-6
時間枠:before induction
Perioperative blood level of IL-6 was recorded
before induction
Blood level of IL-6
時間枠:after incision
Perioperative blood level of IL-6 was recorded
after incision
Blood level of IL-6
時間枠:immediately after extubation
Perioperative blood level of IL-6 was recorded
immediately after extubation
Blood level of IL-10
時間枠:before induction
Perioperative blood level of IL-10 was recorded
before induction
Blood level of IL-10
時間枠:after incision
Perioperative blood level of IL-10 was recorded
after incision
Blood level of IL-10
時間枠:immediately after extubation
Perioperative blood level of IL-10 was recorded
immediately after extubation
Duration of hospital stay
時間枠:from day of surgery until day of discharge from hospital
length of hospital stay (in days)
from day of surgery until day of discharge from hospital

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • スタディチェア:Congcong Chen、Second Affiliated Hospital, School of Medicine, Zhejiang University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (予想される)

2019年8月1日

一次修了 (予想される)

2019年12月31日

研究の完了 (予想される)

2020年12月31日

試験登録日

最初に提出

2019年7月19日

QC基準を満たした最初の提出物

2019年7月31日

最初の投稿 (実際)

2019年8月2日

学習記録の更新

投稿された最後の更新 (実際)

2019年8月2日

QC基準を満たした最後の更新が送信されました

2019年7月31日

最終確認日

2019年7月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する